| Just Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Writing and Speaking > Article Marketing > Article Marketing - How Much Do You Have to Worry About Duplicate Content III |
|
Just Answers - Article Marketing - How Much Do You Have to Worry About Duplicate Content III
If you do that enough, over time, they'll penalize your entire website so that not According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product hing on your website comes up. All of that to say, do not submit content to articl ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in e directories that you have on your own website. Your website should be one-hundre lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. percent original and unique. Having said that, we look at the flip side of the co here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe in and we look at these article directories. If we assume that you submit one art d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro cle to one-hundred article directories, what happens is a lot of the article direc ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc tories will manipulate your article so that the search engines won't catch the fac easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi that it's duplicate content. Generally, if I submit an article to one-hundred di nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically rectories--within about a week or two I'll have fifty links from those directories and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ Then, the other web-masters pick up my content and my link, and put it on their w ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ebsite in combination with other content. And then, I may end up with one-thousand ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a , or fifteen-hundred inbound links from that one article that I've written. If we dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod go back to that one-hundred, we recognize that search engines' have effectively co cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin nsidered fifty of those as being duplicate content. Those results aren't going to tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen how up. It's still very good for me because I end up with fifty inbound links plus t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel whatever anybody else uses those articles for--I get inbound links from those web ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ites. I think that that's enough on duplicate content. The bottom line to all of y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products this is that if you write original content, and submit it to as many directories a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de you want, you will be fine. But do not put it on your web site, and do not rewrit elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e your articles. Write fresh content for best results – and for long-term results tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:
|